Diagonal Therapeutics
Diagonal Therapeutics is a biotechnology company that develops targeted therapies for cancer by integrating molecular biology, genomic data, and translational research to identify and advance precision oncology drug candidates. Its platform focuses on genetically defined cancer dependencies and novel mechanisms of action to create small molecule and biologic therapies that aim to disrupt key pathways driving tumor growth and survival. The company’s research approach combines target discovery, medicinal chemistry, and preclinical validation to progress programs toward clinical evaluation with the goal of addressing unmet needs in oncology. Diagonal Therapeutics also collaborates with academic partners and leverages external datasets to inform its therapeutic strategies and enhance predictive models for treatment response. Its pipeline includes programs across multiple cancer types that are designed to exploit specific genetic or phenotypic vulnerabilities in tumor cells.
Domain
diagonaltx.com
Country
United StatesIndustry
BiopharmaEmployees
11-50
Last Funding
$125.0M
Founded
2021
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Diagonal Therapeutics use?+
Diagonal Therapeutics uses 12 technologies including Google Tag Manager, Next.js, GSAP.
What industry is Diagonal Therapeutics in?+
Diagonal Therapeutics operates in the Biopharma industry.
Where is Diagonal Therapeutics based?+
Diagonal Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026